Will Indonesia’s preordered COVID-19 vaccines protect against new variants?

The recent emergence of new and highly transmissible strains of COVID-19 has cast doubt on whether the vaccine Indonesia has ordered for its ongoing immunization drive would continue to work should the more contagious variants arrive at the nation’s doorstep. The three strains of concern are the B1117 variant first identified in Britain, the B1351 variant detected in South Africa and the B1128 strain first found among Brazilians. Some of these strains have already been found in neighboring countries, but Indonesia still lags behind in genomic sequencing to be able to detect any of them. Read also: Genome surveillance another weak link in Indonesia's coronavirus fight, experts warn Concerns have been mounting globally that these variants could affect ongoing vaccination campaigns, as producers work hard to ensure their immunizing agents would still stimulate the product…

Topics :

  • COVID-19-variants Sinovac-Biotech genomic-surveillance Indonesia South-Africa vaccine effectiveness AstraZeneca

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *

scroll to top